Teva has announced the day-one launch of Latanoprost 0.005% w/v Eye Drops solution 2.5ml, which is indicated in the treatment of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.

Latanoprost is currently available as Xalatan (Latanoprost) from Pfizer Limited but Latanoprost is now available from Teva to fulfil generic prescriptions.

Kim Innes, commercial director at Teva, said: “As the leading generics company in the country and with the widest portfolio of our competitors, Teva continues to lead with strong product launches and patent expired products. This is our inaugural product launch for 2012 and our first day-one patent expiry of the year.

“It’s good for pharmacy, because patent expiries provide them with the opportunities for increasing margins and keeping costs down. But, even more importantly, we’re providing high-quality medicines for patients whilst doing our bit to save the NHS over £9bn a year.”

New or existing customers can order through their wholesaler or local Teva territory sales manager. For more information call 0800 085 8621.